A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment

The present study investigated whether a concentration of serum thymidine kinase 1 (STK1p) could be used to distinguish between healthy individuals, patients with colorectal benign tumors and individuals with colorectal cancer (CRC). The effectiveness of surgery on patients with CRC was monitored. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Dang, Li, Ma, Hongbo, Hei, Ailian, Xu, Shuai, Zhou, Ji, He, Ellen, Skog, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087469/
https://www.ncbi.nlm.nih.gov/pubmed/32257201
http://dx.doi.org/10.3892/mco.2020.2002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087469/
https://www.ncbi.nlm.nih.gov/pubmed/32257201
http://dx.doi.org/10.3892/mco.2020.2002

Ejemplares similares